Showing results (1-10 of 275) with videos related to
Sort By:
Pageof 28
Expert Review of Anticancer Therapy|September 19, 2009
Personalizing therapy for metastatic breast cancerPatrick G Morris, Clifford A HudisExpert Opinion on Pharmacotherapy|April 9, 2009
Therapeutic options for metastatic breast cancerPatrick G Morris, Heather L McArthur, Clifford A HudisBreast (Edinburgh, Scotland)|August 11, 2015
Big data: Are large prospective randomized trials obsolete in the future?Clifford A HudisOncology (Williston Park, N.Y.)|June 7, 2005
Clinical implications of antiangiogenic therapiesClifford A HudisClinical Breast Cancer|December 12, 2003
Current status and future directions in breast cancer therapyClifford A HudisOncology (Williston Park, N.Y.)|November 19, 2002
Single-agent vs combination therapy in advanced breast cancer: potential roles of capecitabineClifford A HudisClinical Breast Cancer|September 14, 2016
Adjuvant Chemotherapy and Trastuzumab Is Safe and Effective in Older Women With Small, Node-Negative, HER2-Positive Early-Stage Breast CancerKaren A Cadoo, Patrick G Morris, Elizabeth P Cowell, et al.The Oncologist|February 1, 2011
Triple-negative breast cancer: an unmet medical needClifford A Hudis, Luca GianniSeminars in Oncology|June 8, 2004
Dose-dense chemotherapy in breast cancer and lymphomaClifford A Hudis, Norbert SchmitzCancer|September 3, 2011
Adjuvant trastuzumab reduces locoregional recurrence in women who receive breast-conservation therapy for lymph node-negative, human epidermal growth factor receptor 2-positive breast cancerAna P Kiess, Heather L McArthur, Kathleen Mahoney, et al.Pageof 28